IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-24315-1.html
   My bibliography  Save this article

Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness

Author

Listed:
  • Huijing Yin

    (Fudan University Shanghai Cancer Center
    Fudan University)

  • Jingshu Wang

    (Fudan University)

  • Hui Li

    (Fudan University)

  • Yinjue Yu

    (Fudan University)

  • Xiaoling Wang

    (Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine)

  • Lili Lu

    (Fudan University Shanghai Cancer Center
    Fudan University)

  • Cuiting Lv

    (Fudan University)

  • Bin Chang

    (Fudan University
    Fudan University Shanghai Cancer Center)

  • Wei Jin

    (The People’s Hospital of Guangxi Zhuang Autonomous Region)

  • Wenwen Guo

    (Fudan University
    Fudan University Shanghai Cancer Center)

  • Chunxia Ren

    (Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine)

  • Gong Yang

    (Fudan University Shanghai Cancer Center
    Fudan University
    Fudan University)

Abstract

Extracellular matrix protein-1 (ECM1) promotes tumorigenesis in multiple organs but the mechanisms associated to ECM1 isoform subtypes have yet to be clarified. We report in this study that the secretory ECM1a isoform induces tumorigenesis through the GPR motif binding to integrin αXβ2 and the activation of AKT/FAK/Rho/cytoskeleton signaling. The ATP binding cassette subfamily G member 1 (ABCG1) transduces the ECM1a-integrin αXβ2 interactive signaling to facilitate the phosphorylation of AKT/FAK/Rho/cytoskeletal molecules and to confer cancer cell cisplatin resistance through up-regulation of the CD326-mediated cell stemness. On the contrary, the non-secretory ECM1b isoform binds myosin and blocks its phosphorylation, impairing cytoskeleton-mediated signaling and tumorigenesis. Moreover, ECM1a induces the expression of the heterogeneous nuclear ribonucleoprotein L like (hnRNPLL) protein to favor the alternative mRNA splicing generating ECM1a. ECM1a, αXβ2, ABCG1 and hnRNPLL higher expression associates with poor survival, while ECM1b higher expression associates with good survival. These results highlight ECM1a, integrin αXβ2, hnRNPLL and ABCG1 as potential targets for treating cancers associated with ECM1-activated signaling.

Suggested Citation

  • Huijing Yin & Jingshu Wang & Hui Li & Yinjue Yu & Xiaoling Wang & Lili Lu & Cuiting Lv & Bin Chang & Wei Jin & Wenwen Guo & Chunxia Ren & Gong Yang, 2021. "Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness," Nature Communications, Nature, vol. 12(1), pages 1-19, December.
    • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24315-1
    DOI: 10.1038/s41467-021-24315-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-24315-1
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-021-24315-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Keyang Xu & Ai Fu & Zhaoyi Li & Liangbin Miao & Zhonghan Lou & Keying Jiang & Condon Lau & Tao Su & Tiejun Tong & Jianfeng Bao & Aiping Lyu & Hiu Yee Kwan, 2024. "Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    2. Zihan Tang & Yanyan Xu & Yun Tan & Hui Shi & Peipei Jin & Yunqi Li & Jialin Teng & Honglei Liu & Haoyu Pan & Qiongyi Hu & Xiaobing Cheng & Junna Ye & Yutong Su & Yue Sun & Jianfen Meng & Zhuochao Zhou, 2023. "CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    3. Yuchao Xia & Zijie Jin & Chengsheng Zhang & Linkun Ouyang & Yuhao Dong & Juan Li & Lvze Guo & Biyang Jing & Yang Shi & Susheng Miao & Ruibin Xi, 2023. "TAGET: a toolkit for analyzing full-length transcripts from long-read sequencing," Nature Communications, Nature, vol. 14(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24315-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.